---
content_type: page
description: This section provides the schedule of lecture topics, case studies, lecturers,
  and assignment due dates for the course.
learning_resource_types: []
ocw_type: CourseSection
title: Calendar
uid: 6eda4710-3eb5-1b0c-1b02-ce3c36372ba4
---

Session Key
-----------

L = Lecture

R = Recitation

E = Exam

Lecturer Key
------------

{{< tableopen >}}
{{< tropen >}}
{{< tdopen >}}


PD = Prof. Peter Dedon

MM = Dr. Mark Murcko

ST = Prof. Steven Tannenbaum


{{< tdclose >}}
{{< tdopen >}}


  CK = Dr. Charles Knutson

  GL = Guest lecturer

  TA = Teaching assistants


{{< tdclose >}}

{{< trclose >}}

{{< tableclose >}}

{{< tableopen >}}
{{< theadopen >}}
{{< tropen >}}
{{< thopen >}}
SES #
{{< thclose >}}
{{< thopen >}}
TOPICS
{{< thclose >}}
{{< thopen >}}
LECTURERS
{{< thclose >}}
{{< thopen >}}
KEY DATES
{{< thclose >}}

{{< trclose >}}

{{< theadclose >}}
{{< tropen >}}
{{< tdopen colspan="4" >}}
**Overview of the Drug Discovery Process; Fundamental Principles**
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
L1
{{< tdclose >}}
{{< tdopen >}}
Introduction and Fundamentals
{{< tdclose >}}
{{< tdopen >}}
PD, MM, ST
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
L2
{{< tdclose >}}
{{< tdopen >}}
Overview of Drug Development 1
{{< tdclose >}}
{{< tdopen >}}
MM
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
L3
{{< tdclose >}}
{{< tdopen >}}
Overview of Drug Development 2
{{< tdclose >}}
{{< tdopen >}}
MM
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
R1
{{< tdclose >}}
{{< tdopen >}}
Fundamentals
{{< tdclose >}}
{{< tdopen >}}
PD
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
L4
{{< tdclose >}}
{{< tdopen >}}
Biochemistry Review Exercise
{{< tdclose >}}
{{< tdopen >}}
CK
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
L5
{{< tdclose >}}
{{< tdopen >}}
Uptake and Distribution
{{< tdclose >}}
{{< tdopen >}}
PD
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
L6
{{< tdclose >}}
{{< tdopen >}}
Dr. Keith Hoffmaster, Novartis: Drug Transporters 1
{{< tdclose >}}
{{< tdopen >}}
GL
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
L7
{{< tdclose >}}
{{< tdopen >}}
Dr. Keith Hoffmaster, Novartis: Drug Transporters 2
{{< tdclose >}}
{{< tdopen >}}
GL
{{< tdclose >}}
{{< tdopen >}}
Drug Metabolism Problem Sets Due
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
R2
{{< tdclose >}}
{{< tdopen >}}
Drug Metabolism 1
{{< tdclose >}}
{{< tdopen >}}
ST
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
L8
{{< tdclose >}}
{{< tdopen >}}
Drug Metabolism 2
{{< tdclose >}}
{{< tdopen >}}
ST
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
L9
{{< tdclose >}}
{{< tdopen >}}
Drug Toxicity 1
{{< tdclose >}}
{{< tdopen >}}
ST
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
R3
{{< tdclose >}}
{{< tdopen >}}
Lecture Review Session
{{< tdclose >}}
{{< tdopen >}}
TA
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
L10
{{< tdclose >}}
{{< tdopen >}}
Drug Toxicity 2
{{< tdclose >}}
{{< tdopen >}}
ST
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
L11
{{< tdclose >}}
{{< tdopen >}}
Pharmacokinetics
{{< tdclose >}}
{{< tdopen >}}
PD
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
R4
{{< tdclose >}}
{{< tdopen >}}
Quiz Review
{{< tdclose >}}
{{< tdopen >}}
PD, TA
{{< tdclose >}}
{{< tdopen >}}


Fundamentals Problem Set Due

Pharmacokinetics Problem Set Due


{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
E
{{< tdclose >}}
{{< tdopen colspan="3" >}}
Exam
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen colspan="4" >}}
**Case Studies and Literature Discussions; Case Study Project**
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
L12
{{< tdclose >}}
{{< tdopen >}}
Case Study: Omeprazole Pharmacogenetics
{{< tdclose >}}
{{< tdopen >}}
PD
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
R5
{{< tdclose >}}
{{< tdopen >}}
Overview of Drug Development 3
{{< tdclose >}}
{{< tdopen >}}
MM
{{< tdclose >}}
{{< tdopen >}}
Case Study Project Topic Due
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
L13
{{< tdclose >}}
{{< tdopen >}}
Case Study
{{< tdclose >}}
{{< tdopen >}}
MM
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
L14
{{< tdclose >}}
{{< tdopen >}}
Case Study: Antibiotics
{{< tdclose >}}
{{< tdopen >}}
CK
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
R6
{{< tdclose >}}
{{< tdopen >}}
Project Help Session
{{< tdclose >}}
{{< tdopen >}}
TA
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
L15
{{< tdclose >}}
{{< tdopen >}}
Case Study
{{< tdclose >}}
{{< tdopen >}}
ST
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
L16
{{< tdclose >}}
{{< tdopen >}}
Dr. Alex Wood, MIT Senior Lecturer / Novartis: Case Study: Oncology Drugs
{{< tdclose >}}
{{< tdopen >}}
GL
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
R7
{{< tdclose >}}
{{< tdopen >}}
Project Help Session
{{< tdclose >}}
{{< tdopen >}}
TA
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
L17
{{< tdclose >}}
{{< tdopen >}}
Case Study: Statins
{{< tdclose >}}
{{< tdopen >}}
PD
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
R8
{{< tdclose >}}
{{< tdopen >}}
Project Help Session
{{< tdclose >}}
{{< tdopen >}}
TA
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
L18
{{< tdclose >}}
{{< tdopen >}}
Case Study: GWAS and Statin Toxicity
{{< tdclose >}}
{{< tdopen >}}
PD
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
L19
{{< tdclose >}}
{{< tdopen >}}
Dr. Bernard Fermini, Pfizer: Case Study: Cardiotoxicity
{{< tdclose >}}
{{< tdopen >}}
GL
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
R9
{{< tdclose >}}
{{< tdopen >}}
Project Help Session
{{< tdclose >}}
{{< tdopen >}}
TA
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
L20
{{< tdclose >}}
{{< tdopen >}}
Dr. Teresa Wright, Shire Pharmaceuticals: Preclinical Drug Development
{{< tdclose >}}
{{< tdopen >}}
GL
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
R10
{{< tdclose >}}
{{< tdopen >}}
Project Help Session
{{< tdclose >}}
{{< tdopen >}}
TA
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
L21
{{< tdclose >}}
{{< tdopen >}}
Dr. Keith Hoffmaster: Case Study: PK / PD
{{< tdclose >}}
{{< tdopen >}}
GL
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
L22
{{< tdclose >}}
{{< tdopen >}}
Case Study: Sarilumab Phase III Clinical Result
{{< tdclose >}}
{{< tdopen >}}
MM
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
R11
{{< tdclose >}}
{{< tdopen >}}
Prof. Doug Lauffenburger: Systems Pharmacology
{{< tdclose >}}
{{< tdopen >}}
GL
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
L23
{{< tdclose >}}
{{< tdopen >}}
Dr. Tess Schmalbach, Schmalbach LLC: The Clinical Size of Drug Development
{{< tdclose >}}
{{< tdopen >}}
GL
{{< tdclose >}}
{{< tdopen >}}
Case Study Project Paper Due
{{< tdclose >}}

{{< trclose >}}

{{< tableclose >}}